154 related articles for article (PubMed ID: 26687776)
1. Association Between X-Ray Cross-complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis.
Lu W; Wu G; Zhang B
Med Sci Monit; 2015 Dec; 21():3978-85. PubMed ID: 26687776
[TBL] [Abstract][Full Text] [Related]
2. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
Chai F; Liang Y; Chen L; Zhang F; Jiang J
Med Sci Monit; 2015 Oct; 21():3231-40. PubMed ID: 26498491
[TBL] [Abstract][Full Text] [Related]
3. Association between XRCC3 T241M polymorphism and glioma risk: a meta-analysis.
Feng Y; Zeng M; Xu Q
Tumour Biol; 2014 Jun; 35(6):5589-92. PubMed ID: 24633885
[TBL] [Abstract][Full Text] [Related]
4. Association between the XRCC3 Thr241Met polymorphism and breast cancer risk: an updated meta-analysis of 36 case-control studies.
Mao CF; Qian WY; Wu JZ; Sun DW; Tang JH
Asian Pac J Cancer Prev; 2014; 15(16):6613-8. PubMed ID: 25169497
[TBL] [Abstract][Full Text] [Related]
5. Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies.
Dashti S; Taherian-Esfahani Z; Keshtkar A; Ghafouri-Fard S
BMC Med Genet; 2019 May; 20(1):79. PubMed ID: 31077156
[TBL] [Abstract][Full Text] [Related]
6. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
Wang Z; Zhang W
Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
[TBL] [Abstract][Full Text] [Related]
7. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.
Yan Y; Liang H; Li T; Guo S; Li M; Qin X; Li S
Leuk Lymphoma; 2014 Sep; 55(9):2130-4. PubMed ID: 24304418
[TBL] [Abstract][Full Text] [Related]
8. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
[TBL] [Abstract][Full Text] [Related]
9. Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis.
Sahami-Fard MH; Mousa Mayali AR; Tajehmiri A
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4599-4608. PubMed ID: 27892671
[TBL] [Abstract][Full Text] [Related]
10. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
11. Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis.
Liu J; Zhou Z; Lai T; Yin J
Tumour Biol; 2014 Feb; 35(2):1083-7. PubMed ID: 24061639
[TBL] [Abstract][Full Text] [Related]
12. XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese.
Liu C; Wang H
Tumour Biol; 2013 Aug; 34(4):2249-54. PubMed ID: 23558966
[TBL] [Abstract][Full Text] [Related]
13. DNA repair gene XRCC3 Thr241Met polymorphisms and lung cancer risk: a meta-analysis.
Bei L; Xiao-Dong T; Yu-Fang G; Jian-Ping S; Zhao-Yu Y
Bull Cancer; 2015 Apr; 102(4):332-9. PubMed ID: 25794597
[TBL] [Abstract][Full Text] [Related]
14. Significant associations between X-ray repair cross-complementing group 3 genetic polymorphisms and thyroid cancer risk.
Yu XL; Liu H; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG; Cai J
Tumour Biol; 2014 Mar; 35(3):2009-15. PubMed ID: 24277376
[TBL] [Abstract][Full Text] [Related]
15. Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.
He XF; Wei W; Su J; Yang ZX; Liu Y; Zhang Y; Ding DP; Wang W
Mol Biol Rep; 2012 May; 39(5):5125-34. PubMed ID: 22161248
[TBL] [Abstract][Full Text] [Related]
16. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.
He XF; Wei W; Li JL; Shen XL; Ding DP; Wang SL; Liu ZZ; Qin JB; Wu LX; Xie DL
Gene; 2013 Jul; 523(1):10-9. PubMed ID: 23562721
[TBL] [Abstract][Full Text] [Related]
17. XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.
Chen X; Wang Z; Yan Y; Li P; Yang Z; Qin L; Mo W
PLoS One; 2014; 9(1):e84195. PubMed ID: 24454720
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the relationship between XRCC3 T241M polymorphism and colorectal cancer susceptibility.
Zhang LZ; Li YS; Liu HZ
Genet Mol Res; 2015 Nov; 14(4):14831-9. PubMed ID: 26600544
[TBL] [Abstract][Full Text] [Related]
19. XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Wu XT
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):226-34. PubMed ID: 24315014
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis.
Li C; Liu Y; Hu Z; Zhou Y
Leuk Lymphoma; 2014 Jun; 55(6):1309-19. PubMed ID: 23978154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
